OpenVSafe by OpenVAERS
Search V-safe

E6U-95746-64221

2 vaccinations 4 coded responses 16 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
926 / CA
Registered
2021-01-18
Relationship
Self

Timeline

  1. 2021-01-18
    Registered in v-safe
  2. 2021-01-18
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-18
    Survey response — day 0, dose 1
    MedDRA: Asthenopia, Eyelid ptosis, Headache, Immediate post-injection reaction — Feeling: Good · Headache
    Free text: Developed a localized headache about 30 minutes after vaccine. Location over right eye and right side of head. Eye felt heavy and droopy but normal on assessment.This resolved within one hour.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-19
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site warmth — Feeling: Good · Site: Pain
    Free text: Injection site warm to touch
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-01-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Injection site erythema, Injection site mass — Feeling: Good · Site: Redness, Swelling
    Free text: Someone else just noticed today at my inj. site, small, slightly red raised area, approx. 2 mm. Redness & raised area not noticed before.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-25
    Health check-in — day 7, dose 1
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  10. 2021-02-01
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-02-08
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-08
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-02-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chest discomfort — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Free text: Heaviness in chest, unable to take deep inspiration
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches
    Adult check-in
  15. 2021-02-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-02-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  17. 2021-02-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  18. 2021-02-15
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-18Pfizer-BioNTech
22021-02-08Pfizer-BioNTech

Free text

Release 2 — day 0, dose 1

2021-01-18

Systemic reaction (other): Developed a localized headache about 30 minutes after vaccine. Location over right eye and right side of head. Eye felt heavy and droopy but normal on assessment.This resolved within one hour.

Release 2 — days 1–6 daily, dose 1

2021-01-19

Systemic reaction (other): Injection site warm to touch

2021-01-24

Systemic reaction (other): Someone else just noticed today at my inj. site, small, slightly red raised area, approx. 2 mm. Redness & raised area not noticed before.

Release 3 — days 1–6 daily, dose 2

2021-02-09

Systemic reaction (other): Heaviness in chest, unable to take deep inspiration

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROAsthenopia ✓ ✓ ✓
SROChest discomfort ✓ ✓ ✓
SROEyelid ptosis ✓ ✓ ✓
SROHeadache ✓ ✓ ✓
SROImmediate post-injection reaction ✓ ✓ ✓
SROInjection site erythema ✓ ✓ ✓
SROInjection site mass ✓ ✓ ✓
SROInjection site warmth ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release